Islet transplantation restores normal levels of insulin receptor and substrate tyrosine phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle and myocardium of streptozocin-induced diabetic rats

Diabetes

Volumn 48, Issue 4, 1999, Pages 801-812

  Giorgino, Francesco ^a   Logoluso, Francesco ^a   Davalli, Alberto M ^b   Napoli, Raffaele ^b   Laviola, Luigi ^a   Hirshman, Michael F ^b   Horton, Edward S ^b   Weir, Gordon C ^b   Smith, Robert J ^b  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; PHOSPHATIDYLINOSITOL 3 KINASE;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; HEART MUSCLE CELL; HORMONAL REGULATION; INSULIN BINDING; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; KIDNEY CAPSULE; MALE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SKELETAL MUSCLE;

EID: 0033061946     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.4.801     Document Type: Article

References (67)

1. Kasuga M, Karlsson FA, Kahn CR: Insulin stimulates the phosphorylation of the β-subunit of its own receptor. Science 217:185-187, 1982
2. Sun XJ, Rothenberg P, Kahn CR, Backer JM, Araki K, Wilden PA, Cahill DA, Goldstein BJ, White MF: Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 352:73-77, 1991
3. Sun XJ, Wang LM, Zhang Y, Yenush L, Myers MG Jr, Glasheen E, Lane WS, Pierce JH, While MF: Role of IRS-2 in insulin and cytokine signalling. Nature 377:173-177, 1995
4. Pronk GJ, McGlade J, Pelicci G, Pawson T, Bos JL: Insulin-induced phosphorylation of the 46- and 52-kDa Shc proteins. J Biol Chem 268:5748-5753, 1993
5. Lavan BE, Lane WS, Lienhard GE: The 60-kDa phosphotyrosine protein in insulin-treated adipocytes is a new member of the insulin receptor substrate family. J Biol Chem 272:11439-11443, 1997
6. Lavan BE, Fantin VR, Chang ET, Lane WS, Keller SR, Lienhard GE: A novel 160-kDa phosphotyrosine protein in insulin-treated embryonic kidney cells is a new member of the insulin receptor substrate family. J Biol Chem 272:21403-21407, 1997
7. Folli F, Saad MJ, Backer JM, Kahn CR: Insulin stimulation of phosphatidylinositol 3-kinase activity and association with insulin receptor substrate 1 in liver and muscle of the intact rat. J Biol Chem 267:22171-22177, 1992
8. Gould GW, Jess TJ, Andrews GC, Herbst JJ, Plevin RJ, Gibbs EM: Evidence for a role of phosphatidylinositol 3-kinase in the regulation of glucose transport in Xenopus oocytes. J. Biol Chem 269:26622-26625, 1994
9. Okada T, Kawano Y, Sakakibara T, Hazeki O, Ui M: Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes: studies with a selective inhibitor wortmannin. J Biol Chem 269:3568-3573, 1994
10. Yeh JI, Gulve EA, Rameh L, Birnbaum MJ: Dissociation of signaling pathways for insulin- and contraction-activated hexose transport: the effects of wortmannin on rat skeletal muscle. J Biol Chem 270:2107-2111, 1995
11. Tsakiridis T, McDowell HE, Walker T, Downes CP, Hundal HS, Vranic M, Klip A: Multiple roles of phosphatidylinositol 3-kinase in regulation of glucose transport, amino acid transport, and glucose transporters in L6 skeletal muscle cells. Endocrinology 136:4315-4322, 1995
12. Shepherd PR, Nave BT, Siddle K: Insulin stimulation of glycogen synthesis and glycogen synthase activity is blocked by wortmannin and rapamycin in 3T3-L1 adipocytes: evidence for the involvement of phosphoinositide 3-kinase and p70 ribosomal protein-S6 kinase. Biochem J 305:25-28, 1995
13. Yamamoto-Honda R, Tobe K, Kaburagi Y, Ueki K, Asai S, Yachi M, Shirouzu M, Yodoi J, Akanuma Y, Yokoyama S, Yazaki Y, Kadowaki T: Upstream mechanisms of glycogen synthase activation by insulin and insulin-like growth factor-I: glycogen synthase activation is antagonized by wortmannin or LY294002 but not by rapamycin or by inhibiting p21ras. J Biol Chem 270:2729-2734, 1995
14. Olson AL, Pessin JE: Regulation of c-fos expression in adipose and muscle tissue of diabetic rats. Endocrinology 134:271-276, 1994
15. Giorgino F, Smith RJ: Dexamethasone enhances insulin-like growth factor-I effects on skeletal muscle cell proliferation: role of specific intracellular signaling pathways. J Clin Invest 96:1473-1483, 1995
16. Chang PY, Goodyear LJ, Benecke H, Markuns JS, Moller DE: Impaired insulin signaling in skeletal muscles from transgenic mice expressing kinase-deficient insulin receptors. J Biol Chem 270:12593-12600, 1995
17. Harada S, Smith KM, Smith JA, White MF, Jarett L: Insulin-induced egr-1 and c-fos expression in 32D cells requires insulin receptor, Shc, and mitogen-activated protein kinase, but not insulin receptor substrate-1 and phosphatidylinositol 3-kinase activation. J Biol Chem 271:30222-30226, 1996
18. Giorgino F, Chen J-H, Smith RJ: Changes in tyrosine phosphorylation of insulin receptors and a 170,000 molecular weight nonreceptor protein in vivo in skeletal muscle of streptozotocin-induced diabetic rats: effects of insulin and glucose. Endocrinology 130:1433-1444, 1992
19. Saad MJA, Araki E, Miralpeix M, White MF, Kahn CR: Regulation of insulin receptor substrate-1 in liver and muscle of animal models of insulin resistance. J Clin Invest 90:1839-1849, 1992
20. Folli F, Saad MJ, Backer JM, Kahn CR: Regulation of phosphatidylinositol 3-kinase activity in liver and muscle of animal models of insulin-resistant and insulin-deficient diabetes mellitus. J Clin Invest 92:1787-1794, 1993
21. Klip A, Ramlal T, Bilan PJ, Cartee GD, Gulve EA, Holloszy JO: Recruitment of GLUT-4 glucose transporters by insulin in diabetic rat skeletal muscle. Biochem Biophys Res Commun 172:728-736, 1990
22. Napoli R, Hirshman MF, Horton ES: Mechanisms and time course of impaired skeletal muscle glucose transport activity in streptozocin diabetic rats. J Clin Invest 96:427-437, 1995
23. Barnard RJ, Youngren JF, Kartel DS, Martin DA: Effects of streptozotocin-induced diabetes on glucose transport in skeletal muscle. Endocrinology 126:1921-1926, 1989
24. Yki-Jarvinen H, Koivisto VA: Continuous subcutaneous insulin infusion therapy decreases insulin resistance in type 1 diabetes. J Clin Endocrinol Metab 58:659-666, 1984
25. Simonson DC, Tamborlane RS, Sherwin RS, Smith JD, DeFronzo RA: Improved insulin sensitivity in patients with type 1 diabetes mellitus after CSII. Diabetes 34:80-86, 1985
26. Pillay TS, Xiao S, Olefsky JM: Glucose-induced phosphorylation of the insulin receptor functional effects and characterization of phosphorylation sites. J Clin Invest 97:613-620, 1996
27. Kroder G, Bossenmaier B, Kellerer M, Capp E, Stoyanov B, Muhlhofer A, Berti L, Horikoshi H, Ullrich A, Haring H: Tumor necrosis factor-alpha- and hyperglycemia-induced insulin resistance: evidence for different mechanisms and different effects on insulin signaling. J Clin Invest 97:1471-1477, 1996
28. Sbraccia P, D'Adamo M, Giaccari A, Morviducci L, Zorretta D, Leonetti F, Caiola S, Buongiorno A, Tamburrano G: Regulation of rat insulin receptor tyrosine kinase by hypoglycemia. Endocrinology 135:2708-2713, 1994
29. Homan M, Nicholson CP, Katz H, Perkins J, Haymond M, Jensen M, Butler P, Rizza R: Effects of chronic systemic insulin delivery on insulin action in dogs. Diabetologia 34:702-708, 1991
30. Davalli AM, Ogawa Y, Scaglia L, Wu YJ, Hollister J, Bonner-Weir S, Weir GC: Function, mass, and replication of porcine and rat islets transplanted into diabetic nude mice. Diabetes 44:104-111, 1995
31. Giorgino F, Almahfouz A, Goodyear LJ, Smith RJ: Glucocorticoid regulation of insulin receptor and substrate IRS-1 tyrosine phosphorylation in rat skeletal muscle in vivo. J Clin Invest 91:2020-2030, 1993
32. Bradford MM: A rapid and sensitive method for quantification of microgram quantities of protein. Anal Biochem 72:248-257, 1976
33. Hirshman MF, Goodyear LJ, Wardzala LJ, Horton ED, Horton ES: Identification of an intracellular pool of glucose transporters from basal and insulin-stimulated skeletal muscle. J Biol Chem 265:987-991, 1991
34. Bers DM: Isolation and characterization of cardiac sarcolemma. Biochim Biophys Acta 555:131-146, 1979
35. Bers DM, Philipson KD, Nishimoto AY: Sodium-calcium exchange and sideness of isolated cardiac sarcolemmal vesicles. Biochim Biophys Acta 601:358-371, 1980
36. Giorgino F, Pedrini MT, Matera L, Smith RI: Specific increase in p85α expression in response to dexamethasone is associated with inhibition of insulin-like growth factor-I stimulated phosphatidylinositol 3-kinase activity in cultured skeletal muscle cells. J Biol Chem 272:7455-7463, 1997
37. Napoli R, Davalli AM, Hirshman MF, Weitgasser R, Weir GC, Horton ES: Islet transplantation under the kidney capsule fully corrects the impaired skeletal muscle glucose transport system of streptozocin diabetic rats. J Clin Invest 97:1389-1397, 1996
38. Patti ME, Sun XJ, Bruening JC, Araki E, Lipes MA, White MF, Kahn CR: 4PS/insulin receptor substrate (IRS)-2 is the alternative substrate of the insulin receptor in IRS-1-deficient mice. J Biol Chem 270:24670-24673, 1995
39. Kelly KL, Ruderman NB: Insulin-stimulated phosphatidylinositol 3-kinase: association with a 185-kDa tyrosine-phosphorylated protein (IRS-1) and localization in a low density membrane vesicle. J Biol Chem 268:4391-4398, 1993
40. Heller-Harrison RA, Morin M, Guilherme A, Czech MP: Insulin-mediated targeting of phosphatidylinositol 3-kinase to GLUT4-containing vesicles. J Biol Chem 271:10200-10204, 1996
41. Yang J, Clarke JF, Ester CJ, Young PW, Kasuga M, Holman GD: Phosphatidylinositol 3-kinase acts at an intracellular membrane site to enhance GLUT4 exocytosis in 3T3-L1 cells. Biochem J 313:125-131, 1996
42. Welham MJ, Bone H, Levings M, Learmonth L, Wang LM, Leslie KB, Pierce JH, Schrader JW: Insulin receptor substrate-2 is the major 170-kDa protein phosphorylated on tyrosine in response to cytokines in murine lymphohemopoietic cells. J Biol Chem 272:1377-1381, 1997
43. Sharfe N, Roifman CM: Differential association of phosphatidylinositol 3-kinase with insulin receptor substrate (IRS)-1 and IRS-2 in human thymocytes in response to IL-7. J Immunol 159:1107-1114, 1997
44. Temaru R, Urakaze M, Satou A, Yamazaki K, Nakamura N, Kobayashi M: High glucose enhances the gene expression of interleukin-8 in human endothelial cells, but not in smooth muscle cells: possible role of interleukin-8 in diabetic macroangiopathy. Diabetologia 40:610-613, 1997
45. Asakawa H, Miyagawa J, Hanafusa T, Kuwajima M, Matsuzawa Y: High glucose and hyperosmolarity increase secretion of interleukin-1 beta in cultured human aortic endothelial cells. J Diabetes Complications 11:176-179, 1997
46. Ahmad F, Goldstein BJ: Alterations in specific protein-tyrosine phosphatases accompany insulin resistance of streptozotocin diabetes. Am J Physiol 268:E932-E940, 1995
47. Hauguel-de Mouzon S, Peraldi P, Alengrin F, Van Obberghen E: Alteration of phosphotyrosine phosphatase activity in tissues from diabetic and pregnant rats. Endocrinology 132:67-74, 1993
48. Almira EC, Garcia AR, Boshell BR: Insulin binding and glucose transport activity in cardiomyocytes of a diabetic rat. Am J Physiol 250:E402-E406, 1986
49. Barrett EJ, Schwartz RG, Young LH, Jacob R, Zaret BL: Effect of chronic diabetes on myocardial fuel metabolism and insulin sensitivity. Diabetes 37:943-948, 1988
50. Garvey WT, Hardin D, Juhaszova M, Dominguez JH: Effects of diabetes on myocardial glucose transport system in rats: implications for diabetic cardiomyopathy. Am J Physiol 264:H837-H844, 1993
51. Anai M, Funaki M, Ogihara T, Terasaki J, Inukai K, Katagiri H, Fukushima Y, Yazaki Y, Kikuchi M, Oka Y, Asano T: Altered expression levels and impaired steps in the pathway to phosphatidylinositol 3-kinase activation via insulin receptor substrates 1 and 2 in Zucker fatty rats. Diabetes 47:13-23, 1998
52. Kerouz NJ, Horsch D, Pons S, Kahn CR: Differential regulation of insulin receptor substrates-1 and -2 (IRS-1 and IRS-2) and phosphatidylinositol 3-kinase isoforms in liver and muscle of the obese diabetic (ob/ob) mouse. J Clin Invest 100:3164-3172, 1997
53. Rondinone CM, Wang LM, Lonnroth P, Wesslau C, Pierce JH, Smith U: Insulin receptor substrate (1RS) 1 is reduced and IRS-2 is the main docking protein for phosphatidylinositol 3-kinase in adipocytes from subjects with non-insulin-dependent diabetes mellitus. Proc. Natl Acad Sci U S A 94:4171-4175, 1997
54. Strodter D, Overbeck A, Syed Ali S, Seitz S, Bretzel RG, Federlin K: Improvement of cardiac performance and metabolism in long-term diabetes mellitus after treatment with insulin. Exp Clin Endocrinol Diabetes 103:354-360, 1995
55. Stroedter D, Schmidt T, Bretzel RG, Federlin K: Glucose metabolism and left ventricular dysfunction are normalized by insulin and islet transplantation in mild diabetes in the rat. Acta Diabetol 32:235-243, 1995
56. Chatham JC, Forder JR: Relationship between cardiac function and substrate oxidation in hearts of diabetic rats. Am J Physiol 273:H52-H58, 1997
57. Davidoff AJ, Ren J: Low insulin and high glucose induce abnormal relaxation in cultured adult rat ventricular myocytes. Am J Physiol 272:H159-H167, 1997
58. Wang PH, Almahfouz A, Giorgino F, McCowen KC, Smith RJ: In vivo insulin signaling in the myocardium of streptozocin-diabetic rats: opposite effects of diabetes on insulin stimulation of glycogen synthase and c-fos. Endocrinology 140:1141-1150, 1999
59. Rice KM, Lienhard GE, Garner CW: Regulation of the expression of pp160, a putative insulin receptor signal protein, by insulin, dexamethasone, and 1-methyl-3-isobutylxanthine in 3T3-L1 adipocytes. J Biol Chem 267: 10163-10167, 1992
60. Ricort JM, Tanti JF, Van Obberghen E, Le Marchand-Brustel Y: Alterations in insulin signalling pathway induced by prolonged insulin treatment of 3T3-L1 adipocytes. Diabetologia 38:1148-1156, 1995
61. Ido Y, Vindigni A, Chang K, Stramm L, Chance R, Heath WF, DiMarchi RD, Di Cera E, Williamson JR: Prevention of vascular and neural dysfunction in diabetic rats by C-peptide. Science 277:563-566, 1997
62. Zierath JR, Galuska D, Johansson BL, Wallberg-Henriksson H: Effect of human C-peptide on glucose transport in in vitro incubated human skeletal muscle. Diabetologia 34:899-901, 1991
63. Zierath JR, Handberg A, Tally M, Wallberg-Henriksson H: C-peptide stimulates glucose transport in isolated human skeletal muscle independent of insulin receptor and tyrosine kinase activation. Diabetologia 39:306-313, 1996
64. Tanti JF, Gremeaux T, Grillo S, Calleja V, Klippel A, Williams LT, Van Obberghen E, Le Marchand-Brustel Y: Overexpression of a constitutively active form of phosphatidylinositol 3-kinase is sufficient to promote Glut 4 translocation in adipocytes. J Biol Chem 271:25227-25232, 1996
65. Martin SS, Haruta T, Morris AJ, Klippel A, Williams LT, Olefsky JM: Activated phosphatidylinositol 3-kinase is sufficient to mediate actin rearrangement and GLUT4 translocation in 3T3-L1 adipocytes. J Biol Chem 271:17605-17608, 1996
66. Frevert EU, Kahn BB: Differential effects of constitutively active phosphatidylinositol 3-kinase on glucose transport, glycogen synthase activity, and DNA synthesis in 3T3-L1 adipocytes. Mol Cell Biol 17:190-198, 1997
67. Davalli AM, Napoli R, Weitgasser R, Capotorto JV, Hirshman MF, Finegood DT, Bonner-Weir S, Horton ES, Weir GC: Long-term normalization of GLUT-4 protein content in skeletal muscle of diabetic rats following islet transplantation. J Endocrinol 150:255-263, 1996